PRVB

Provention Bio, Inc. Common Stock
PRVB

Overview Fund Activity
Delisted

PRVB was delisted on the 26th of April, 2023.

Back to rankings

48 hedge funds and large institutions have $42.2M invested in Provention Bio, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 14 increasing their positions, 3 reducing their positions, and 7 closing their positions.

Holders
48
Holders Change
+20
Holders Change %
+71.43%
% of All Funds
1.05%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
27
Increased
14
Reduced
3
Closed
7
Calls
$164K
Puts
$447K
Net Calls
-$283K
Net Calls Change
-$279K

Top Buyers

1
DM
1
Deerfield Management
New York
$4.95M
2
SCM
2
Segantii Capital Management
Hong Kong
$4.95M
3
PA
3
Perceptive Advisors
New York
$4.55M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$9.08M
5
MS
5
Maven Securities
Jersey
$1.7M

Top Sellers

1
EP
1
Eversept Partners
New York
$0
2
IG
2
ING Group
Netherlands
$0
3
EGI
3
EAM Global Investors
California
$125K
4
EI
4
EAM Investors
California
$96K
5
SSA
5
Schonfeld Strategic Advisors
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
IG
51
ING Group
Netherlands
– -$467K -38,600 Closed
SSA
52
Schonfeld Strategic Advisors
New York
– -$282K -23,300 Closed
BAM
53
Blueshift Asset Management
New Jersey
– -$206K -17,061 Closed
Renaissance Technologies
54
Renaissance Technologies
New York
– -$189K -15,600 Closed
Acadian Asset Management
55
Acadian Asset Management
Massachusetts
– -$72K -5,956 Closed
1 2
3